Tuesday, August 19, 2014

CBSA Announces 2014 BioWest Venture Showcase Finalists

Colorado BioScience Association (CBSA) will hold its BioWest Conference, September 10, 2014, at the Marriott City Center, Denver. The three finalists in the 2014 Venture Showcase competition at BioWest include: dBMEDx, Littleton; KromaTiD, Inc., Fort Collins; Mighty Oak Medical, Englewood.

Colorado BioScience Association announces the 2014 BioWest Conference, September 10, at the Marriott City Center, 1701 California Street, Denver. The announcement is made by CBSA President and CEO April Giles, who says, “BioWest is the Rocky Mountain region's premier medical device and biotechnology conference that brings together the industry for a one-day only conference that includes the Venture Showcase competition." 

The Venture Showcase finalists pitch their technologies and business plans in front of a live audience at BioWest to a panel of bioscience experts and venture capitalists. The winner, announced at the end of the conference day, will receive a $7,500 cash prize.

The three finalists in the 2014 Venture Showcase competition include:

dBMEDx - Littleton dBMEDx is developing breakthrough, real-time clinical decision and patient monitoring devices using our patented, non-invasive scanning technology. Visit: http://www.dbmedx.com.

KromaTiD, Inc. - Fort Collins KromaTiD is dedicated to creating new products for disease research, mutation detection and chromosome analysis. Visit: http://www.kromatid.com.

Mighty Oak Medical - Englewood Mighty Oak is developing a prize-winning spine technology that features an affordable and disposable option for surgical navigation. Visit: http://www.mightyoakmedical.com.

About BioWest 2014 | September 10, 2014

The BioWest Conference is a one day event attended by more than 300 industry leaders, government representatives, executives, researchers, investors and entrepreneurs. The conference features speakers Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (her ‘Update on the FDA’ keynote will occur at 4:45 p.m.) and keynote panelists; Jandel Allen-Davis, M.D., Vice President, Government and External Relations, Kaiser Permanente Colorado; James Hill, Ph.D. is Professor of Pediatrics and Medicine at the University of Colorado School of Medicine; Len Tacconi, President, HMR Weight Management Services Corp., a subsidiary of Merck & Co. Inc.; and Russell Slifer, Director, United States Patent and Trademark, Rocky Mountain Regional Office. The full schedule of the day’s events is found at: http://www.cobioscience.com/biowest/schedule.

Conference Registration is now open at http://www.CoBioScience.com/BioWest. Rates for members start at $325 and $375 for non-members and passes for the expo hall and reception only are $125 for members and $150 for non-members. Group rates are available for companies and organizations. The conference also includes an Exhibit Hall with over 40 exhibitors showcase new technologies, products and services to attendees.

Link to the Business Wire Release

Link to the PitchEngine Social Media Release

New BioWest Pre-Event Sept 9: Digital Health Venture Showcase

In collaboration with the PrIME Health Collaborative, CBSA is co-hosting the BioWest pre-event, the 2014 Digital Health Venture Showcase on September 9 (1 to 9 p.m.) at CSU Denver, 475 17th Street, 2nd Floor Atrium (this is the final pitch event for the Finance Track of PrIME’s Digital Health Challenge). The event will feature a curated, vetted selection of pitches from the best and brightest Colorado digital health companies. These finalist companies will vie for a share of $50,000 in prizes awarded by PrIME in partnership with the Colorado Health Foundation. To register, visit: http://cobioscience.site-ym.com/events/event_details.asp?id=487688.

Note: the final pitch event for the Access Track of PrIME’s ‘Digital Health Challenge @ Denver Startup Week’ is on September 17th, where finalists will pitch live in front of a panel of health care executives and a group of more than 100 interested onlookers. For more information, visit: http://primehealthco.com/about/challenge/.

Monday, August 18, 2014

DBJ: 'Amgen [Foundation] supports STEM effort' + Other Coverage

Quoting from the August 8th Good Works column:

"The Colorado BioScience Association [Colorado BioScience Institute] received $25,000 from the Amgen Foundation, which will support its Research Experience for Teachers program. The four-week program is for teachers of STEM subjects — science, technology, engineering and math — from seventh to 12th grades. Teachers will be placed in local life-science companies for real-world lab experience that can then be translated into class lessons."

Link to the DBJ

Other coverage of Amgen's donation:

Link to the MarketWatch posting

Link to the BioSpace posting

Link to the Bloomberg/BusinessWeek posting

Link to InnovatioNews

Friday, August 8, 2014

Video Overview: CBSA 2014 Women In Bioscience Symposium

The CBSA Women in Bioscience Symposium 2014 was held Wednesday, July 23, 2014, at the University of Colorado BioFrontiers Institute, Jennie Smoly Caruthers Biotechnology Building. The keynote was presented by Kathy Glaub, former President, Plexxikon and a FireceBiotech's 2011 Women in Biotech: Video recap:

Women In Bioscience 2014: April Giles, CBSA Pres/CEO Opening Remarks

Kathy Glaub: Challenges From Big Pharma

Kathy Glaub: Lessons Learned At Plexxikon

Kathy Glaub: Personal Advice to Women In Bioscience

Women In Bioscience 2014 HR Professionals Panel: Terumo BCT Strategies For Growth
http://youtu.be/i4xVZVcrn9w - Laura Roybal, Talent Acquisition Manager, Terumo BCT

Women In Bioscience 2014 HR Professionals Panel: About Array BioPharma
http://youtu.be/MpTl6y0NXD0 - Sherri Norland, Array BioPharma 

Women In Bioscience 2014 HR Professionals Panel: 
About Tolmar
http://youtu.be/V9fdI0ZfwnQ - Gayvaughn Marnich, TOLMAR

Women In Bioscience 2014 HR Professionals Panel: Advice For Job Seekers
http://youtu.be/yuzXetJwQAg -Laura Roybal, Talent Acquisition Manager, Terumo BCT

Women In Bioscience 2014 HR Professionals Panel: Work Your Network
http://youtu.be/r0GTRvQgwd8 - Sherri Norland, Array BioPharma 

Women In Bioscience 2014 HR Professionals Panel: Personal Networking Example
http://youtu.be/JTZOFeiQIuQ - Gayvaughn Marnich, TOLMAR

Dr Leslie Leinwand, CSO, BioFrontiers Institute: Her Story

Speed Mentoring
The symposium concluded with a speed mentoring session: a fast, fun, facilitated session for attendees to connect to women leaders in bioscience. Participating Mentors included:

* Eliana Rivera Burke, Senior Director of Business Development, BARC USA

* Nicole Garneau, PhD, Curator and Chair of the Health Sciences Department, Denver Museum of Nature & Science

* April Giles, President and CEO, Colorado BioScience Association

* Kathy Glaub, Former President, Plexxikon

* Clara Li (her table is pictured in the foreground above), VP Regulatory Affairs, Clinipace Worldwide

* Jeannine Looney, SWQA Manager, Covidien Surgical Solutions

* Heather Potters, Global Business Development Officer, Co-Chairman, PharmaJet, Inc.

After ten minutes, attendees circulated to another mentor's table.

Jeannine Looney, far right:

Heather Potters, center:

Eliana Rivera Burke, center:
 Kathy Glaub, center:  
Nicole Garneau, PhD, left,center:

Wednesday, August 6, 2014

CompanyWeek Profiles Colorado's Sharklet Technologies, the 2010 Venture Showcase Winner at BioWest

Quoting from the August 5th CompanyWeek:

"Sharkskin-like texture is proving a formidable foe to bacteria in applications as varied as medical devices and iPhone cases for Mark Spieckers’ growth-minded company.

A bacteria thwarting, shark inspired iPhone case might sound appealing to parents with ice cream and chocolate smeared iPhones but that’s just a foot in the door for second-stage Sharklet Technologies. The company, which moved to Aurora’s Anschutz Medical Campus from Florida in 2010, uses the unique properties of shark’s skin as an inspiration to reduce bacteria-related infections in medical devices.

Really? From medical devices to iPhone cases? 'There’s a significant market for iPhone cases,' explains Sharklet CEO Mark Spiecker. 'Everybody knows what an iPhone case is, and when I walk into a meeting and show him or her our technology it’s a very tangible thing,' he says. He shows the data on how the case repels bacteria based on Sharklet’s patented technologies. Hence a company focused on medical devices and planning to debut its first products this year is starting out with an iPhone case under $30."
Link to the full CompanyWeek profile

Sharklet CEO Mark Spiecker presenting at the 2010 Venture Showcase competition held at the CBSA BioWest Conference and Expo. 
Link to the announcement of Sharklet's winning 2010 Venture Showcase presentation

Link to an interview with Mark Spiecker at last year's Rocky Mountain Life Science Investor and Partnering Conference

Venture Showcase is back in 2014 - Sept 10th at BioWest

Quoting from the CBSA website:

"Four emerging life science companies will be selected to present at the 2014 BioWest Venture Showcase to pitch their technology and business plan to a panel of bioscience experts and investors. One outstanding company will be selected for $7,500 cash award, announced at the BioWest Closing Reception."

Link for more information about BioWest 2014

Monday, August 4, 2014

Read about Pet Cancer Drugs, including CBSA 2012 Venture Showcase winner VetDC, in the NY Times

Quoting from the August 1 article by Andrew Pollack about pet cancer drugs, including Fort Collins-based Vet DC:

"VetDC was founded to take advantage of another trend: Pharmaceutical companies increasingly are testing their drugs on pets to get an early read on how the drug might work in people.

For instance, Gilead Sciences stopped work on a drug it was developing to treat lymphoma in people. But studies had already shown “beautiful data in people’s pets,” said Steven Roy, a former Amgen executive who runs VetDC. So VetDC is now developing that drug for lymphoma in dogs."

Link to The New York Times

Steven Roy (center) receives the cash prize for VetDC's 2012 win in the Colorado BioScience Association Venture Showcase competition. 

Link to the overview of VetDC's 2012 winning Venture Showcase presentation
Venture Showcase is back in 2014 - Sept 10th at BioWest

Quoting from the CBSA website:

"Four emerging life science companies will be selected to present at the 2014 BioWest Venture Showcase to pitch their technology and business plan to a panel of bioscience experts and investors. One outstanding company will be selected for $7,500 cash award, announced at the BioWest Closing Reception."

Link for more information about BioWest 2014

Monday, July 21, 2014

Amgen Foundation Grants $25K to a Colorado STEM Education program

Colorado BioScience Association is honored to announce the Amgen Foundation’s grant of $25,000 to the Colorado BioScience Institute in support of the Research Experience for Teachers (RET) program in Colorado’s science classrooms.

The RET program is an intensive, 4 week, hands-on program for 7th-12th grade teachers. This inaugural year, four teachers were selected to participate. The RET program places teachers in local life science companies to provide them with hands-on lab experience to bridge real-world skills to back the classroom.

The goal is to help build long-term collaborative partnerships between, industry scientists, and the local university research community by involving the teachers in real bioscience research and helping them translate their research experiences and new knowledge into classroom activities.
2014 RET Hosting Companies:
Biodesix, Inc., Aurora, Boulder Molecular diagnostics advancing personalized medicine www.biodesix.com
iC42 Clinical Research & Development, Aurora Contract research services for integrated solutions to systems biology www.bioanalytics.us
Sharklet Technologies, Inc., Aurora Engineers surface technologies (Sharklet™) that controls the growth of dangerous bacteria www.sharklet.com 
Surefire Medical Inc., Westminster Developing a novel infusion system for the interventional radiology market www.surefiremedical.com

The Amgen Foundation seeks to advance science education, improve patient access to quality care, and strengthen the communities where Amgen staff members live and work. To date, the Foundation has donated more than $200 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally. For more information, visit http://www.amgen.com/citizenship/overview.html and follow us on http://www.twitter.com/AmgenFoundation.
Link to the Business Wire
Link to the PitchEngine Social Media Release

Tuesday, July 15, 2014

DBJ: "Med devices drive Colorado bioscience industry"

Quoting from the July 4th posting:

"Colorado’s bioscience industry has grown in recent years on the strength of its medical device companies, its medical labs and specialized medical distribution while other niches and the industry nationwide haven’t fared as well.

Colorado bucked the national trend of declining employment in life sciences and actually expanded payrolls 11 percent, according to a 2014 biennial study of U.S. life sciences published by the industry association BIO and the Battelle life-science consulting group."

Link to the Denver Business Journal